Amarin Corp Plc (AMRN)

[jessellivermore]

studyTS....

I think this is one of these AdComs where the FDA takes charge and simply ignores the panel...The subject is too complex...and the panel is not intelligent, sophisticated, or knowledgeable enough to make an informed decision...

FDA will understand the the stat argument supports primaries at risk...and the necessity to lower their numbers before they become secondaries...

The panel is one antagonist (a bomb thrower) and a bunch of mentally challenged MDs..I think the Tufts guy is going to pay for this down the line when he gets to be the guy who voted against Vascepa...

":>) JL